Lertec (modafinil) And The Risk Of Congenital Anomalies

Alertec (modafinil) is being recalled in Canada because it may increase the risk of birth defects when used during pregnancy. The recall affects all Alertec products distributed across Canada. Pregnant women or those who may become pregnant should be aware of this safety concern with this medication.

Reason
Product safety
Category
drug recall
Country
Canada
Agency
HC-DRUGS
Recall date
2019-06-20
Status
Ongoing
Distribution
Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/f37d9fe0-e094-457c-9851-610b0fbe2edc